Use the Back button in your browser to see the other results of your search or to select another record.

Detailed Search Results

Exercise improves glycaemic control in women diagnosed with gestational diabetes mellitus: a systematic review [with consumer summary]
Harrison AL, Shields N, Taylor NF, Frawley HC
Journal of Physiotherapy 2016 Oct;62(4):188-196
systematic review

QUESTION: Does exercise improve postprandial glycaemic control in women diagnosed with gestational diabetes mellitus? DESIGN: A systematic review of randomised trials. PARTICIPANTS: Pregnant women diagnosed with gestational diabetes mellitus. INTERVENTION: Exercise, performed more than once a week, sufficient to achieve an aerobic effect or changes in muscle metabolism. OUTCOME MEASURES: Postprandial blood glucose, fasting blood glucose, glycated haemoglobin, requirement for insulin, adverse events and adherence. RESULTS: This systematic review identified eight randomised, controlled trials involving 588 participants; seven trials (544 participants) had data that were suitable for meta-analysis. Five trials scored >= 6 on the PEDro scale, indicating a relatively low risk of bias. Meta-analysis showed that exercise, as an adjuvant to standard care, significantly improved postprandial glycaemic control (MD -0.33 mmol/l, 95% CI -0.49 to -0.17) and lowered fasting blood glucose (MD -0.31 mmol/l, 95% CI -0.56 to -0.05) when compared with standard care alone, with no increase in adverse events. Effects of similar magnitude were found for aerobic and resistance exercise programs, if performed at a moderate intensity or greater, for 20 to 30 minutes, three to four times per week. Meta-analysis did not show that exercise significantly reduced the requirement for insulin. All studies reported that complications or other adverse events were either similar or reduced with exercise. CONCLUSION: Aerobic or resistance exercise, performed at a moderate intensity at least three times per week, safely helps to control postprandial blood glucose levels and other measures of glycaemic control in women diagnosed with gestational diabetes mellitus. REGISTRATION: PROSPERO CRD42015019106.

Full text (sometimes free) may be available at these link(s):      help